Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria

被引：0
|
作者：
Jonathan Graham
Doreen McBride
Donald Stull
Anna Halliday
Stamatia Theodora Alexopoulos
Maria-Magdalena Balp
Matthew Griffiths
Ion Agirrezabal
Torsten Zuberbier
Alan Brennan
机构：
[1] RTI Health Solutions,Department of Dermatology and Allergy, Allergy
[2] RTI Health Solutions,Centre
[3] Novartis Pharmaceuticals UK Limited,Charité
[4] Novartis Pharma AG,undefined
[5] Costello Medical Consulting Ltd,undefined
[6] Charité-University Hospital Berlin,undefined
[7] University of Sheffield,undefined
来源：
PharmacoEconomics | 2016年 / 34卷
关键词：
Urticaria; Scenario Analysis; Omalizumab; Chronic Urticaria; Spontaneous Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 827
页数：12
相关论文
共 50 条
  • [1] Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
    Graham, Jonathan
    McBride, Doreen
    Stull, Donald
    Halliday, Anna
    Alexopoulos, Stamatia Theodora
    Balp, Maria-Magdalena
    Griffiths, Matthew
    Agirrezabal, Ion
    Zuberbier, Torsten
    Brennan, Alan
    PHARMACOECONOMICS, 2016, 34 (08) : 815 - 827
  • [2] COST-UTILITY OF OMALIZUMAB COMPARED WITH STANDARD OF CARE FOR THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIA (CSU)
    Graham, J.
    McBride, D.
    Stull, D.
    Halliday, A.
    Alexopoulos, S. T.
    Balp, M.
    Griffiths, M.
    Agirrezabal, I
    Brennan, A.
    VALUE IN HEALTH, 2015, 18 (07) : A423 - A423
  • [3] Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria
    Kanters, T. A.
    Thio, H. B.
    Hakkaart, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (03) : 702 - 708
  • [4] COST-EFFECTIVENESS OF OMALIZUMAB FOR THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIA IN FRANCE
    Cariou, C.
    Duteil, E.
    Benjamin, K.
    Duco, J.
    VALUE IN HEALTH, 2016, 19 (07) : A568 - A568
  • [5] Profile of omalizumab in the treatment of chronic spontaneous urticaria
    Labrador-Horrillo, Moises
    Ferrer, Marta
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 4909 - 4915
  • [6] Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
    Maurer, Marcus
    Rosen, Karin
    Hsieh, Hsin-Ju
    Saini, Sarbjit
    Grattan, Clive
    Gimenez-Arnau, Ana
    Agarwal, Sunil
    Doyle, Ramona
    Canvin, Janice
    Kaplan, Allen
    Casale, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10): : 924 - 935
  • [7] Omalizumab in chronic spontaneous urticaria
    Martin Marques, Marta
    De Dios Lopez, Anna
    Jornet Montana, Sonia
    Sanchez Parada, Lucia
    Lopez Broseta, Pilar Ana
    del Estal Jimenez, Jorge
    Canela Subirada, Montserrat
    Canadell Vilarrasa, Laura
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 223 - 223
  • [8] COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA IN THE NETHERLANDS
    Kanters, T. A.
    Gertsen, K.
    Hakkaart, L.
    VALUE IN HEALTH, 2015, 18 (07) : A423 - A423
  • [9] Predictive cytokines of omalizumab in the treatment of chronic spontaneous urticaria
    Ji, Ping
    Chen, Hao
    Yang, Yaqi
    Yang, Lin
    Wang, Yin
    Liu, Guanghui
    Zhu, Rongfei
    CYTOKINE, 2025, 185
  • [10] Treatment of Chronic Spontaneous Urticaria: a Focused Update in Omalizumab
    Blackwell, Whitney A.
    Khan, David A.
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2019, 6 (03) : 175 - 188
12345